Efficacy and safety of recombinant human granulocyte colony-stimulating factor in patients with unexplained recurrent pregnancy loss: a protocol for a multicenter, randomized, double-blind, controlled trial - Mu, Fangxiang; Cai, Zhuhua; Du, Lirong; Zeng, Xianghui; Zhou, Qi; Chen, Yaolong; Wang, Fang (Current controlled trials in cardiovascular medicine, 2025)
Keywords: Abortion, Habitual - diagnosis; Abortion, Habitual - drug therapy; Abortion, Habitual - prevention & control; Adult; Autoimmune diseases; Birth rate; Care and treatment; China; Clinical medicine; Congenital diseases; Disease; Diseases; Double-Blind Method; Evidence-based medicine; Female; Gestational Age; Granulocyte colony-stimulating factor; Granulocyte Colony-Stimulating Factor - administration & dosage; Granulocyte Colony-Stimulating Factor - adverse effects; Granulocyte Colony-Stimulating Factor - therapeutic use; Granulocytes; Hospitals; Humans; Immunology; Informed consent; Leukocytes; Medical research; Medicine, Experimental; Multicenter Studies as Topic; Neutrophils; Patient safety; Pregnancy; Pregnancy outcome; Pregnant women; Randomized controlled trial; Randomized Controlled Trials as Topic; Recombinant Proteins - administration & dosage; Recombinant Proteins - adverse effects; Recombinant Proteins - therapeutic use; Relapse; Reproductive health; Study Protocol; Time Factors; Treatment Outcome; Unexplained recurrent pregnancy loss; Uterus; Womens health; China; Granulocyte colony-stimulating factor; Randomized controlled trial; Pregnancy outcome; Unexplained recurrent pregnancy loss